|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for GLAXOSMITHKLINE P (NYSE:GSK) Stock.
GSK stock opening price was $41.78 per share.
Current price of NYSE:GSK Stock is $41.44 per share
and it is
$-0.02, (-0.05%) today
and it was trading in the daily range of $41.29 - 41.83 per share.
Current Bid Price for (NYSE:GSK) stock is $40.00 and the Ask Price is $41.77. In the last 52 weeks
GSK stock was trading in the range of $27.15 - 42.18. 50-Day Moving Average for (NYSE:GSK) stock is
$40.377 and 200-Day Moving Average is $37.2417. On average analysts predict that One Year Target Estimated price for
(NYSE:GSK) stock is $42.15.
GLAXOSMITHKLINE P (NYSE:GSK) Market capitalization is $105.1B. (NYSE:GSK) stock average daily volume is
1,367,980 shares per day.
However, on last trading session of Nov 13, 2009
GSK stock traded 2,206,878 shares.
Also The Short Ratio for (NYSE:GSK) stock is 2.80.
On previous trading session GSK Stock closed at $41.46 per share.
Last year GLAXOSMITHKLINE P (NYSE:GSK) before taxes (EBITDA) (ttm) earned $17.737B on total revenue of $44.999B.
Earnings Per Share - EPS (ttm) for GSK stock is 3.17.
Also, (NYSE:GSK) Stock Price Per Earnings ratio - P/E is 13.08.
Thus, (NYSE:GSK) Stock Price/Sales (ttm) ratio is 2.34 and Price/Book (mrq) ratio is 6.84.
(NYSE:GSK) Stock pays a dividend of $1.855 per share which is a yield of 4.47%.
So at this time (NYSE:GSK) Stock maintains Trailing Annual Dividend Rate at 1.855
.
StockRing Recommendations for GLAXOSMITHKLINE P (NYSE:GSK) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=GSK
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
GSK Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
 | |
| 1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
| 1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
| 5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
| 5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
GSK Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
| Last Trade: |
41.44 |
| Trade Time: |
Nov 13 |
| Change: |
-0.02, (-0.05%) |
| Prev Close: |
41.46 |
| Open: |
41.78 |
| Bid: |
40.00 |
| Ask: |
41.77 |
| 1y Target Est: |
$42.15 |
| 50-Day Moving Average: |
40.377 |
200-Day Moving Average:
|
37.2417 |
| Short Ratio: |
2.80 |
| Trailing Annual Dividend Rate: |
1.855
|
|
| Day's Range: |
41.29 - 41.83 |
| 52wk Range: |
27.15 - 42.18 |
| Volume: |
2,206,878 |
| Avg Vol: |
1,367,980 |
| Market Cap: |
105.1B |
| P/E (ttm): |
13.08 |
| EPS (ttm): |
3.17 |
| Div & Yield: |
1.855 (4.47%) |
| Revenue (ttm): |
44.999B |
| Earnings before Tax (EBITDA) (ttm): |
17.737B |
| Price/Sales (ttm): |
2.34 |
| Price/Book (mrq): |
6.84 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS | |
| |
|
GLAXOSMITHKLINE PLC (NYSE: GSK) Company Information
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
United Kingdom - Map
Phone: 44 20 8990 9000
Fax: 44 20 8990 4321
Web Site: http://www.gsk.com
GLAXOSMITHKLINE PLC (NYSE: GSK) DETAILS
GLAXOSMITHKLINE PLC (NYSE: GSK) Index Membership: N/A
GLAXOSMITHKLINE PLC (NYSE: GSK) Sector: Healthcare
GLAXOSMITHKLINE PLC (NYSE: GSK) Industry: Drug Manufacturers - Major
GLAXOSMITHKLINE PLC (NYSE: GSK) Full Time Employees: 99,003
GLAXOSMITHKLINE PLC (NYSE: GSK) BUSINESS SUMMARY
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. It operates in two segments, Pharmaceutical and Consumer Healthcare. The Pharmaceutical segment offers prescription medicines in the therapeutic areas, such as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital, oncology, emesis, and dermatology. This segment markets approximately 25 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment offers OTC medicines, such as alli, a weight loss medicine; Panadol, a paracetamol/acetaminophen analgesic; smoking control products under the NicoDerm, NiQuitin CQ, Nicabate, and Nicorette names; and other brands, including Breathe Right nasal strips, Tums, Citrucel, Contac, and FiberChoice. Its oral healthcare products comprise Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; Sensodyne, a range of toothpastes and toothbrushes, including Pronamel to protect from acid erosion; Biotene, a treatment for dry mouth; Polident, PoliGrip, and Corega, the denture care cleansers and adhesives; and other brands, including Odol, Macleans, and Dr Best. This segment also provides nutritional healthcare products, such as Lucozade, a range of energy and sports drinks; Horlicks, a range of milk-based malted food and chocolate drinks; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline operates in the United States, Europe, Japan, the Asia Pacific, the Middle East, Latin America, Africa, and Canada. The company was founded in 1935 and is based in Brentford, the United Kingdom.
GLAXOSMITHKLINE PLC (NYSE: GSK) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Andrew Witty , Age: 44
Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee Salary: $ 2.80M Bonus: N/A
Mr. Julian Heslop , Age: 55
Chief Financial OffiAge: cer, Exec. Director, Member of Fin. Committee and Member of Corp. Admin. & Transactions Committee Salary: $ 1.48M Bonus: N/A
Dr. Moncef Slaoui , Age: 49
Chairman of R&D, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee Salary: $ 1.75M Bonus: N/A
Mr. Herve Gisserot ,Age:
Pres Age: N/A Salary: Bonus: N/A
Mr. David Lechleiter ,Age:
Chief Exec. Officer of GSK Romania Salary: N/A Bonus: N/A
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Glaxo H1N1 Vaccine Approved - Analyst Blog
Benzinga - Nov 13, 2009
GlaxoSmithKline plc (GSK) recently received approval from the US Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. The FDA approved the supplemental ...
Zacks Analyst Blog Highlights: Hewlett Packard Company, 3Com Corporation, Cisco Systems Inc., Wal-Mart Stores Inc. and GlaxoSmithKline, plc - Press Releases
Benzinga - Nov 13, 2009
Chicago, IL – November 13, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting ...
Analyst - Zacks Analyst Blog Highlights: Hewlett Packard Company, 3Com Corporation, Cisco Systems Inc., Wal-Mart Stores Inc. and GlaxoSmithKline, plc - Ad-Hoc-News
Stiefel Oak Hill facility to close
Albany Times Union - Nov 13, 2009
By LARRY RULISON, Business writer DURHAM -- GlaxoSmithKline PLC is planning to close the Stiefel factory here in Oak Hill by 2012. The closure would lead to the loss of 263 jobs at the plant ...
China VS. India: Stock Picks From Citi Investment Research
The Wall Street Transcript - Nov 12, 2009
November 12, 2009 - The Wall Street Transcript has just published Pharmaceuticals Report offering a timely review of the Pharmaceuticals sector. This 76 page feature contains expert industry ...
Correction: XenoPort-Glaxo drug
The Associated Press - Nov 11, 2009
NEW YORK — In a Nov. 9 story and headline about a Food and Drug Administration review of a drug being developed by XenoPort Inc. and GlaxoSmithKline PLC, The Associated Press reported ...
|
|
BG Group, Glaxo, Prudential, RBS: UK, Irish Equity PreviewBloombergThe stock climbed 2.75 pence, or 3.4 percent, to 84.35 pence. GlaxoSmithKline Plc (GSK LN): The UK's largest drugmaker is scheduled to report results. ...ARM Holdings, BP, Glaxo, RBS, Yell: UK, Irish Equity PreviewBloombergLloyds, National Express, Shell: UK, Irish Equity PreviewBloombergall 9 news articles » |
|
|
No comments:
Post a Comment